The FDA cleared St. Jude Medical Inc.’s EnSite Fusion Registration Module, a software designed to help physicians create detailed heart models to facilitate the diagnosis and delivery of therapy for complex abnormal atrial heart rhythms, including Atrial Fibrillation (AF).

The software integrates an EnSite System-created chamber model with a 3D computed tomography (CT) model so that the physician has an improved view of the heart’s anatomy.


Additional Content

Feature | PACS | John Freeland

People in healthcare technology love to talk about digital transformation like it just started happening. Cloud ...

Time June 29, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | PACS

May 14, 2026 — Ardent Health, a provider of healthcare in mid-sized urban communities across the U.S., has partnered ...

Time May 14, 2026
arrow
News | PACS

Aug. 26, 2025 — Core Sound Imaging, the company behind the widely established Studycast medical imaging workflow ...

Time August 26, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

December 20, 2023 — Terran Biosciences, Inc., a biotech platform company developing therapeutics and technologies for ...

Time December 20, 2023
arrow
Subscribe Now